Ajuste direto para aquisição de T1823 - TRASTUZUMAB DERUXTECANO [100 MG;PÓ CONC SOL INJ; FRS]

ID 11587078 · Portal BASE
Price
Base Price
€15,876,800 .00
Effective Price
€0 .00 -100.0%
Contract Details
Contract Type
Aquisição de bens móveis
Procedure
Ajuste Direto Regime Geral
CPV Code
33600000
Location
Portugal, Lisboa, Lisboa
Bidder Count
—
Winner
DAIICHI SANKYO PORTUGAL UNIPESSOAL, LDA.
NIF 501509860
Company
Dates
Publication
16 Jul 2025
Celebration
20 Jun 2025
Contracting Entity
Instituto Português de Oncologia de Lisboa Francisco Gentil, EPE
NIF 506361616
Public body
Data Source
Portal BASE
Api · synced 2026-04-17
Risk Flags
Score 100 · HIGH RISK
A1 · Repeat Direct Award
A1_REPEAT_DIRECT_AWARD
HIGH
Authority
86
Supplier
522
Number of Awards
7
Rule
A1 repeat direct award: 7 awards within 36 months
Detected 2026-03-06
A2 · Late Publication
A2_PUBLICATION_AFTER_CELEBRATION
HIGH
Publication Date
16 Jul 2025
Signing Date
20 Jun 2025
Days Late
26
Rule
A2/A3 late publication: 26 days after signing (threshold: 10)
Detected 2026-03-06
A9 · Abnormal Price Reduction
A9_PRICE_REDUCTION
LOW
Base price
15876800.0
Total effective price
0.0
Ratio
0.0
Direction
reduction
Rule
A9 price reduction: ratio 0.0 outside [0.5, 1.5]
Detected 2026-03-06